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Abstract 
 
Aims: 
This study aimed to determine the role of the renin-angiotensin system (RAS) in high 
salt (HS) diet-induced left ventricular hypertrophy (LVH). 
Methods and Results: 
Swiss mice were subjected to regular salt (RS) diet (0.6% NaCl), HS diet (4% NaCl) 
and HS plus irbesartan (50 mg/kg/day) or ramipril (1 mg/kg/day). After 8 weeks, arterial 
pressure was similar in all groups and similar to baseline, whereas LV/body weight ratio was 
higher in HS mice than in RS mice (p<0.005). There were also significant increases in 
collagen density, ACE activity, AT1 receptor density and extracellular signal-regulated kinase 
(ERK1/2) phosphorylation in the left ventricle. Interestingly, increases in wall thickness and 
ERK1 phosphorylation were more marked in the septum than in the rest of the left ventricle. 
Irbesartan or ramipril treatment prevented LVH and the increase in ERK phosphorylation and 
reduced collagen content and AT1 upregulation but upregulated AT2 receptors.  
Conclusions: 
In normal mice, HS diet induces septum-predominant LVH and fibrosis through 
activation of the cardiac RAS-ERK pathway, which can be blocked by irbesartan or ramipril, 
indicating a key role of the cardiac RAS in HS diet-induced LVH.  
 
 
 
Key Words: High salt diet; Left ventricular hypertrophy; Blood pressure; Renin 
angiotensin system; Mitogen-activated protein kinases; Mice 
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Introduction 
Left ventricular hypertrophy (LVH) contributes to cardiovascular morbidity and 
mortality. High salt (HS) intake affects not only arterial pressure but also left ventricular mass 
and cardiac fibrosis in hypertensive rats [1-3] and may participate in LVH in hypertensive 
patients [5]. Interestingly, in normal rats, HS intake has been shown to induce LVH [1, 3, 5-7] 
and interstitial fibrosis [3, 6] with an increased blood pressure [3] or without changes in blood 
pressure [1, 5-7] or sympathetic activity [1, 5]. However, the mechanisms involved in HS 
intake-induced LVH in normal animals, especially the role of the renin-angiotensin system 
(RAS) need to be clarified. It has been shown that during HS loading, a depletion of 
circulating RAS occurs [7-10] while myocardial angiotensin II increased in normal or Dahl 
salt-sensitive rats [8, 9]. Interestingly, during HS loading, angiotensin AT1 receptor mRNA 
and/or protein increased in the heart of normal rats [7, 8]. Inhibition of the RAS by losartan or 
perindopril reduced HS intake-induced LVH in Dahl salt-sensitive rats or partial renal 
ablation-induced hypertensive rats, independently of blood pressure change [2, 10]. These 
segmental data suggest that the cardiac RAS may be activated during HS intake. Therefore, to 
clarify the role of the cardiac RAS in HS diet-induced LVH and to evaluate the cellular 
signalling pathways involved, normal mice were subjected to different salt diets in the 
absence and presence of irbesartan (AT1 blocker) or ramipril (ACE inhibitor). LV posterior 
and septal wall thicknesses were measured using echocardiography. Blood pressure was 
followed in conscious mice and the cardiac RAS was assessed by measuring ACE activity and 
angiotensin II receptor binding capacity in the left ventricle. Since mitogen-activated protein 
kinases, including extracellular signal-regulated kinases (ERK), c-Jun NH(2)-terminal kinases 
(JNK) and p38, mediate angiotensin II-induced LVH [11], the activation or not of these 
signalling pathways in the heart may help to determine whether the cardiac RAS is activated 
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during salt loading. For this purpose, the expression and activation (phosphorylation) of 
ERK1/2, JNK and p38 in the left ventricle were determined.  
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Methods 
All animals were handled according to the Guidelines for the care and use of 
laboratory animals published by the US NIH (NIH publication No. 86-23, revised 1985) and 
to the animal protection law of France. Swiss mice (male; 8 weeks of age; n=12 per group; 
Charles River Laboratories France) were subjected to either regular salt diet (0.6% NaCl, RS), 
high salt diet (4% NaCl, HS), HS diet plus ramipril (HS+Ramipril), or HS diet plus irbesartan 
(HS+Irbesartan) for 8 weeks. Salt was incorporated into the chow by the manufacturer. Based 
on previous studies in mice [12, 13], doses of 1 mg/kg/day of ramipril
 
and 50 mg/kg/day of 
irbesartan were used. Drugs were added to the drinking water. Water was changed 3 times per 
week. Ramipril and irbesartan concentrations were adjusted to achieve an intake of
 
~1 
mg/kg/day and ~50 mg/kg/day respectively, based on the measured water intakes of animals 
in each group. After completing in-vivo experiments, hearts were excised from the animals. In 
six mice from each group, the heart was frozen in liquid nitrogen cooled-isopentane and 
stored at -80°C for subsequent histological and receptor binding studies. In the six other mice 
from each group, the atria and right ventricle were removed and the left ventricle (LV) was 
dissected into the septum and free wall according to the natural limit of the right ventricle. 
Left ventricular, right ventricular and total atrial weights were measured and tissues rapidly 
frozen in liquid nitrogen for tissue assays.  
 
Blood pressure measurements 
Systolic blood pressure (SBP) was monitored by the tail cuff technique in all mice in 
the conscious state at baseline, 4 and 8 weeks with the aid of a computerized system. At each 
time point, 10-15 values were averaged for each mouse. 
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Echocardiography 
Echocardiographic studies were performed at baseline, and at 4 and 8 weeks in mice 
anaesthetized with a mixture of ketamine (65 µg/g), acepromazine (2 µg/g), and xylazine (13 
µg/g). Mice were positioned prone on a warmed bag containing physiological solution and a 
9-Mhz transducer (VINGMED CFM750 echocardiograph) was placed under the bag. The 
parasternal short-axis view at the level of two papillary muscles was used to position the M-
mode cursor perpendicular to the LV posterior and septal walls. For each study, 3-5 
consecutive cardiac cycles were analyzed. Measured parameters were: heart rate; LV diameter 
at the end of diastole and systole; LV fractional shortening defined as (LV end-diastolic 
diameter - LV end-systolic diameter)/LV end-diastolic diameter x100; LV posterior wall 
thickness and septal wall thickness at the end of diastole and systole 
 
Left ventricular fibrosis analysis 
Hearts were cut into 4-µm sections which were mounted onto slides and stained with 
picosirius red F3BA (0.1% solution in saturated aqueous picric acid) to colour collagen. 
Interstitial fibrosis in the LV free wall and the septum was measured using Image-Pro Plus 5.0 
(Micromécanique, Evry, France) and results were expressed as a percentage of the total area. 
In each heart, 6 to 8 images were analyzed. 
 
Cardiac angiotensin converting enzyme activity  
Cardiac ACE activity was measured as previously described [14]. Briefly, LV samples 
were homogenized in Tris · HCl (pH 7.4) and centrifuged at 1000g. The collected supernatant 
was then centrifuged at 15000g. The resulting pellet was dissolved in 1 ml Tris · HCl with 
8.5 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate and incubated at 37°C 
in the presence of z-Phe-His-Leu-OH (Bachem) and Na-Tris · HCl (50 mM HCl, 1% NaCl, 
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pH 8). A negative control was included for each sample by addition of enalaprilat (10
-5
 M). 
The reaction was stopped by the addition of 10% trichloroacetic acid and centrifugation. The 
supernatant was then incubated for 10 min at 37°C after addition of NaOH (0.28N) and o-
phthaldialdehyde (Sigma) and the reaction was stopped by HCl (2N). Fluorometric 
measurements were done at 365 nm excitation and 500 nm emission (F-2000 Fluorescence 
Spectrophotometer, Hitachi). ACE activity was normalized to total protein in the supernatant 
(Bio-Rad protein assay). 
 
In-situ autoradiographic quantitative receptor binding assay  
Angiotensin II binding studies were performed in transverse heart cryosections (10 µm) 
as previously described [15]. Consecutive
 
sections were incubated for 15 min at room 
temperature in a buffer (pH 7.4) containing 0.3 mM bacitracin, 10
 
mM sodium phosphate, 150 
mM NaCl, 1 M EDTA and 0.2% proteinase-free bovine serum albumin to remove 
endogenous bound ligand. Thereafter, the sections were transferred and incubated for 30 
minutes in the
 
same mixture without the bacitracin, in the presence or absence, of
 
losartan 
(AT1 blocker, 0.5 µM, Merck Sharp & Dohme-Chibret), PD-123319 (AT2 blocker, 0.5 µM, 
Sigma) or angiotensin II (0.5
 
µM, Sigma). Finally, the sections were incubated for 90 min in
 
the presence of 32 pM (3-[
125
I]iodotyrosyl
4
,Sar
1
-Ile
8
)Angiotensin II (2000 Ci/mmol;
 
Amersham) with or without losartan, PD-123319, or angiotensin
 
II (same concentrations as 
above) to identify AT2, AT1,
 
and angiotensin II specific binding sites, respectively. After 
being
 
washed and dried, the sections were exposed to imaging plates
 
with a range of known 
amounts of (3-[
125
I]iodotyrosyl
4
,Sar
1
-Ile
8
)Angiotensin II and were quantified using the
 
Bio-
Imaging Analysis system (Fuji MacBAS 1000, Fuji Medical Systems).
 
Pixels accumulated 
within the LV section were normalized
 
for surface area and converted to fmol/mm
2
 by direct 
density comparison with the (3-[
125
I]iodotyrosyl
4
,Sar
1
-Ile
8
)Angiotensin II calibration curve. 
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Cardiac ERK, JNK and p38 expressions by Western blot analysis 
The frozen LV free wall and septum were separately pulverized, homogenized and 
centrifuged. Sample proteins (40 µg/lane) contained in the supernatant were size-fractionated 
by SDS-polyacrylamide gels (10 %, 3h) and transferred to PVDF membranes. A prestained 
protein-weight marker and a control sample (used for normalization) were loaded onto each 
gel. After blocking non specific binding sites, membranes were probed with specific 
antibodies to detect total and phosphorylation levels of  ERKs, JNKs and p38 (Santa Cruz 
Biotechnology, 1:5000 for all total forms, 1:2500, 1:1000 and 1:1000 respectively for ERK, 
JNK and p38 phosphorylated forms, diluted in 2% milk TTBS, 1.5 h). Subsequently, the 
membranes were incubated with horseradish peroxidase-conjugated anti-rabbit IgG (1:5000, 
1h). Specific immunoreactive proteins were detected by enhanced chemiluminescence 
(Amersham) and quantified densitometrically. ERKs, JNKs or p38 phosphorylation level was 
expressed as the ratio of the phosphorylated form to the total form. 
 
Statistical analysis 
Statistical analyses were performed using StatView software (v5, Abacus Concepts 
Inc). Results are expressed as mean±SEM. One-way analysis of variance for repeated 
measures was used for intra-group studies. Two-way analysis of variance was performed for 
comparisons between groups at the same stage. If there was a significant difference, Student-
Newman-Keuls multiple comparison test was used to identify differences between means. 
When only two means were compared, an appropriate Student’s t-test was used. A p< 0.05 
was considered significant. 
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Results 
At baseline and at 8 weeks, body weight was similar between groups. No difference 
was detected among groups for food intake (Table 1). In contrast, water intake was nearly 
doubled in HS, HS/Irbesartan and HS/Ramipril mice compared with LS mice (Table 1). In the 
preliminary study, we verified the effect of HS diet on blood sodium, creatinine and protein 
concentrations and did not observe any significant difference between HS mice (serum 
sodium: 151±2 mmol/l; serum creatinine: 31±2 mmol/l; serum protein: 422 g/l) and LS mice 
(serum sodium: 149±3 mmol/l; serum creatinine: 32±3 mmol/l; serum protein: 422 g/l). 
 
Blood pressure and cardiac pathology  
At baseline, there was no difference between groups with regard to SBP. Eight weeks 
of HS diet alone or with irbesartan or ramipril did not affect SBP (Table 1). Similar results 
were also observed after 4 weeks of salt diet and treatment (data not shown).  
Compared with RS mice, heart weight and heart/body weight ratio were significantly 
increased in HS mice. This was essentially due to increases in LV mass (+17±4%, p<0.001) 
and LV/body weight ratio (+23±6%, p<0.005). These increases were absent in HS+Irbesartan 
and HS+Ramipril mice (Table 1).  
HS diet significantly increased interstitial fibrosis in the LV free wall and in the 
septum (Fig.1). Treatment with irbesartan or ramipril markedly reduced the collagen 
deposition. 
 
Left ventricular dimensional parameters and left ventricular function  
Heart rate was similar for all groups at baseline and after 8 weeks (Table 1). LV 
dimensional and functional parameters were similar at baseline for all groups. After 8 weeks 
of salt diet, LV end-diastolic diameter and fractional shortening were similar in all groups 
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(Table 1). In contrast to RS mice, HS mice showed a slight increase in LV posterior end-
diastolic wall thickness but a marked and significant increase in septal end-diastolic wall 
thickness (Fig.2).  
Treatment with irbesartan or ramipril prevented the increases in LV posterior end-
diastolic wall thickness and septal end-diastolic wall thickness (Fig.2) 
At 8 weeks, calculated LV mass using echocardiography showed that LV end-diastolic 
diameter, LV posterior end-diastolic wall thickness and septal end-diastolic wall thickness 
was closely correlated with LV mass at autopsy (y= 0.94 x+0.50, r=0.852, p<0.0001). 
 
Cardiac angiotensin converting enzyme activity  
ACE activity in the left ventricle was significantly higher in HS and HS+Irbesartan 
mice than in RS mice, indicating an activated cardiac ACE during HS diet, which was not 
affected by irbesartan. LV ACE activity in HS+Ramipril mice was similar to that in RS mice, 
indicating an effective ACE inhibition by ramipril (Table 1). 
 
Angiotensin II receptors in the left ventricle  
In-situ binding assay showed that LV density of AT1 receptors in HS mice was 2-fold 
higher than in RS mice (Fig.3). In HS+Irbesartan mice, LV AT1 density was significantly 
lower than that of HS mice. In HS+Ramipril mice, LV AT1 density was significantly lower 
than that of HS mice and HS+irbesartan mice. 
In RS mice, LV density of AT2 receptors was lower than AT1 density (Fig.3). HS did 
not change AT2 density while treatment with irbesartan or ramipril significantly increased 
AT2 density in the left ventricle, which was more pronounced in ramipril-treated than in 
irbesartan-treated mice.  
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ERK, JNK and p38 expressions  
ERK1/2 phosphorylation in the LV tissue increased significantly after 8 weeks of HS 
diet,  as indicated by > 50% increases in phosphorylated ERK1 and ERK2 (Fig.4). The 
increase in phosphorylated ERK1 was more marked in the septum than in the rest of the LV 
wall. Treatment with irbesartan or ramipril completely prevented ERK1/2 activation. The total 
ERK1/2 protein levels were similar whatever the animal group. 
HS diet did not modify the expression and phosphorylation of JNK or p38 (Table 2). 
Neither irbesartan nor ramipril modified the expression and phosphorylation of these proteins.  
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Discussion 
The present study confirms that HS diet in normal mice induces LV hypertrophy and 
fibrosis, independently of arterial pressure. However, two novel findings were observed: 1) 
HS diet-induced LVH in normal mice mainly occurs at the interventricular septum and 2) this 
septum-predominant LVH is related to the activation of cardiac RAS, which can be prevented 
by an ACE inhibitor or AT1 receptor blocker. 
In normal rodents, most studies have shown no effect of HS intake on blood pressure 
[1, 5-7]. Similarly, we did not observe any significant effect of 4% salt diet on blood pressure. 
This can be explained by a physiological regulation of water-electrolyte homeostasis through 
increasing diuresis in response to HS loading. In accordance with a previous study [12], we 
did not observe any effect of ramipril and irbesartan on blood pressure. This is in line with a 
depressed circulating RAS during salt loading [7-10]. 
Our data showing that HS diet-induced ventricular hypertrophy predominantly 
occurred in the ventricular septum is particularly interesting because previous studies in 
humans have shown a high prevalence of disproportionate ventricular septal hypertrophy in 
different pathologies (aortic valvular disease, pulmonary or essential hypertension) [16-18]. 
The reasons why the interventricular septum is more susceptible to developing hypertrophy 
remain unclear. This may be related to its embryonic development during which three 
components participate in its formation [19] or to its relatively flatter contour compared with 
the LV free wall, which results in a greater systolic stress being applied to it [20]. 
Previous studies have given seemingly contradictory messages about the RAS in HS 
intake-induced LVH. In hypertensive rats fed with DOCA+salt, inhibition of the RAS did not 
affect LVH [21, 22] while in rats fed with HS alone, losartan or perindopril reduced LVH [2, 
10]. Our data showing that both irbesartan and ramipril prevented HS diet-induced LVH 
indicate a role of the RAS in normal mice. Accordingly, we found an increase in cardiac ACE 
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activity in HS mice, which persisted during irbesartan treatment but was inhibited by ramipril. 
We also found a 2-fold increased AT1 receptor binding capacity in the LV tissue of HS mice, 
which was partially attenuated by irbesartan or ramipril. In addition, the activation of ERK1/2 
in the LV tissue of HS mice also supports an activated cardiac RAS because ERK1/2 mediates 
angiotensin II-induced LVH [11]. Overall, these data indicate that a HS diet activates the 
cardiac RAS to stimulate LVH and fibrosis.  
Generally, AT2 receptors oppose the action of AT1 receptors and participate in the 
inhibitory effect of AT1 antagonism or ACE inhibition on hypertrophy and fibrosis through 
activation of kinins and intracellular cGMP signalling [23, 24]. Our study showed that 
irbesartan or ramipril treatment augmented AT2 density in the LV tissue. This might allow 
accumulated angiotensin during irbesartan treatment or angiotensin I during ramipril 
treatment to stimulate AT2 receptors to generate nitric oxide. However, since we did not 
examine the role of AT2 receptors, the significance of the AT2 receptor upregulation induced 
by irbesartan and ramipril needs further investigation. 
This study did not examine the role of aldosterone in HS diet-induced LVH and 
fibrosis. However, a potential role of aldosterone should not be ignored because a HS diet can 
increase expression and activity of aldosterone synthase and increase aldosterone 
concentrations in rat hearts [7, 9] and aldosterone antagonism prevents HS loading-induced 
LVH and fibrosis [25]. Furthermore, angiotensin II can stimulate the adrenal gland to produce 
aldosterone while aldosterone combined with HS intake increases cardiac angiotensin AT1 
receptor density [26]. All of these data indicate a complicated interaction between angiotensin 
and aldosterone in the renin-angiotensin-aldosterone system. Also, our data showing that 
irbesartan or ramipril completely prevented LVH but only partially prevented fibrosis may 
suggest a potential role of aldosterone in this setting. 
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The mechanism by which a HS diet induces the activation of the RAS has not been 
completely elucidated. It is known that HS intake depletes circulating angiotensin II, which 
upregulates angiotensin AT1 receptors. Unlike circulating angiotensin II, cardiac angiotensin 
II concentration is increased [8, 9] due to augmented cardiac ACE activity during HS loading, 
which stimulates AT1 receptors to initiate hypertrophic signalling pathways. Increased AT1 
receptors can also be activated by mechanical stress [27] due to increased arterial pressure 
during nocturnal activity in animals. Another possible mechanism involved in the activation 
of the RAS by high salt may be related to the increased cardiac aldosterone concentration 
during HS loading [7, 8], which upregulates cardiac AT1 receptors [25]. 
Previous studies have demonstrated different roles for the three branches of mitogen-
activated protein kinases. In transgenic mice, specific activation of JNK in the heart did not 
induce cardiac hypertrophy but caused lethal cardiomyopathy in juvenile animals [28] 
whereas specific activation of p38 in the heart induced heart failure with a thinned ventricular 
wall [29]. In contrast, specific activation of ERK1/2 in the heart caused a prominently 
hypertrophic response [30]. Accordingly, we found that a HS diet selectively activated ERKs, 
with a predominant ERK1 activation in the septum, but not JNK or p38. The absence of 
ERK1/2 activation and septum-predominant ventricular hypertrophy in irbesartan or ramipril-
treated mice further supports a role of the AT1 receptor-ERK1/2 pathway in HS induced 
ventricular hypertrophy. 
One limitation of our study is that cardiac angiotensin II levels were not measured. In 
addition, due to the inability of the technique used to finely distinguish regional changes in 
angiotensin AT1 receptors in small hearts, we could not determine LV regional changes in 
AT1 receptors.  
In summary, this study shows that in normal mice, the first impact of HS intake on the 
cardiovascular system is a cardiac remodelling effect. This effect is related to selective 
   
 1 5  
upregulation of the cardiac RAS, which initiates activation of the mitogen-activated protein 
kinases cascade, especially the phosphorylation of ERK1/2. Blockade of the RAS at the ACE 
or AT1 receptor level inhibited ERK1/2 activation, and thereby septum-predominant 
ventricular hypertrophy and interstitial fibrosis. Since LVH in humans is associated with 
cardiovascular mortality and morbidity and septal hypertrophy is highly prevalent in different 
cardiovascular diseases, our data may be relevant in the clinical setting. 
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Figure legends 
Fig.1. Eight weeks of high salt diet increased interstitial fibrosis while irbesartan or ramipril 
treatment limited interstitial fibrosis. (A) Representative left ventricular (LV) tissues stained 
with Picrosirius red (presented at a magnification of X 10). (B) Quantitative morphometric 
analysis of interstitial fibrosis. (n=5 in each group). * p<0.05 versus RS mice and † p<0.05 
versus HS mice. 
Fig.2. High salt (HS) diet slightly increased LV end-diastolic posterior wall thickness but 
markedly increased end-diastolic ventricular septal wall thickness. These changes were 
completely prevented by either irbesartan or ramipril treatment. n=12 in each group. * p<0.05 
versus baseline, † p<0.05 versus RS mice and ‡ p<0.05 versus HS mice after 8 weeks. 
Fig.3. (3-[
125
I]iodotyrosyl
4
,Sar
1
-Ile
8
)Angiotensin II binding in LV sections. A: Pseudocolour 
images of LV sections from mice subjected to regular salt (RS) or high salt (HS) diet and HS 
mice treated with irbesartan (HS+Irbesartan) or ramipril (HS+Ramipril) for 8 weeks. LV 
sections were incubated with (3-[
125
I]iodotyrosyl
4
,Sar
1
-Ile
8
)Angiotensin II alone (AT: total 
angiotensin II binding) or in the presence of unlabelled angiotensin II, PD-123319, or losartan 
which showed the nonspecific (NS), AT1 and AT2 binding, respectively. B: Mean values of 
AT1 and AT2 densities in the left ventricle (n=5 in each group). C: Typical calibration curve 
and corresponding quantification. * p<0.05 versus RS mice, † p<0.05 versus HS mice, ‡ 
p<0.05 versus HS+Irbesartan and § p<0.05 versus corresponding AT1 value. 
Fig.4. A. Typical examples illustrate the expression of phosphorylated ERK1/2 (pERK1 and 
pERK2) and total ERKs (ERK1 and ERK2) proteins in the left ventricle (except septum) and 
septal wall in response to regular salt (RS), high salt (HS) diet and treatment with irbesartan 
(HS+Irbesartan) or ramipril (HS+Ramipril). B and C. ERK1/2 phosphorylation levels were 
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calculated as % of total ERK1/2. HS diet for 8 weeks significantly increased the 
phosphorylation of ERK1/2. The increase in pERK1 was greater in the septum than in the left 
ventricle excluding the septum. n=6 in each group. * p<0.05 versus RS mice; † p<0.05 versus 
HS mice and ‡ p<0.05 versus LV wall. 
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Table 1. Arterial pressure, body weight, heart weight, heart rate, LV diameter and fractional 
shortening measured by echocardiography, plasma renin activity and cardiac ACE activity 
                                                           RS                     HS              HS+Irbesartan     HS+Ramipril 
                                                        (n=12)                (n=12)                (n=12)                 (n=12) 
Systolic blood pressure, mmHg 
    Baseline 
    8 weeks 
 
1253 
1272 
 
1234 
1263 
 
1242 
1252 
 
1242 
1221 
Body weight, g 
Baseline 
8 weeks 
 
33.90.8 
42.61.3‡ 
 
34.80.6 
42.51.0‡ 
 
33.40.6 
42.11.0‡ 
 
33.20.6 
41.90.8‡ 
Food intake, g/24h 6.40.2 6.70.3 6.30.2 6.20.3 
Water intake, ml/24h 6.00.8 10.90.5 * 11.20.4 * 12.51.2 * 
Heart weight, mg 1886 2185 * 1783 † 1845 † 
Heart /body weight ratio 4.30.1 5.30.1 * 4.20.1 † 4.40.2 † 
LV weight 
#
, mg 1354 1585 * 1282 † 1326 † 
LV/body weight ratio 
#
 2.90.1 3.60.2 * 3.10.1 † 3.10.2 † 
Heart rate, beats/min 
      Baseline 
      8 weeks 
 
28416 
25713 
 
27315 
27013 
 
29412 
26713 
 
29112 
27010 
LVEDD, mm 
Baseline 
     8 weeks 
 
4.40.1 
4.80.1‡ 
 
4.40.1 
4.80.1‡ 
 
4.40.1 
4.70.1‡ 
 
4.40.1 
4.70.1‡ 
Fractional shortening, % 
      Baseline 
 
341 
 
331 
 
303 
 
332 
   
 2 5  
      8 weeks 356 342 341 322 
     
Cardiac ACE activity 
#
, 
nmol /mg protein 
3.40.3 5.60.3* 5.50.2* 3.90.2† 
 
RS: regular salt diet (0.6% NaCL); HS: high salt diet (4% NaCl); HS+Irbesartan: HS diet plus 
irbesartan (50 mg/kg/day); HS+Ramipril: HS diet plus ramipril (1 mg/kg/day); LV: left 
ventricle; LVEDD: LV end-diastolic diameter. # LV weight and LV/Body weight ratio were 
measured in 6 mice of each group after 8 weeks of salt diets and treatments. # cardiac ACE 
activity were measured in 5 mice in each group. There was no difference in systolic blood 
pressure between groups at baseline and after 8 weeks of salt diet and treatment. * p<0.05 
versus RS mice, † p<0.05 versus HS and ‡ p<0.05 versus corresponding baseline. 
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Table 2. Phosphorylation of JNKs and p38 in different regions of the left ventricle 
  RS 
(n=6) 
HS 
(n=6) 
HS+Irbesartan 
(n=6) 
HS+Ramipril 
(n=6) 
JNK1 phosphorylation (% ) 
LV except septum 1054 1088 1116 1057 
Septum 986 1057 1086 1006 
JNK2 phosphorylation (% ) 
LV except septum 983 1058 986 897 
Septum 1037 1085 1169 1028 
p38 phosphorylation (% ) 
LV except septum 962 985 993 993 
Septum 1025 965 1074 1073 
Phosphorylation was calculated as the ratio of phosphorylated form to total form x100. 
 
